煥一生物(AliveX Biotech)一直致力于用 AI+多組學(xué)解碼人體免疫,從底層理解生物學(xué)本質(zhì),高效賦能新型生物標(biāo)志物和靶點(diǎn)研發(fā),解決復(fù)雜醫(yī)學(xué)問(wèn)題。AliveX 平臺(tái)解決方案,通過(guò)創(chuàng)新高效端到端的技術(shù)平臺(tái),加快生物標(biāo)志物與靶點(diǎn)的發(fā)現(xiàn)速度,并提高治療靶點(diǎn)篩選的精準(zhǔn)度,顯著提升研發(fā)效率與成功率,引領(lǐng)下一代生命科學(xué)研發(fā)新范式。(143words)
?
AliveX generates and combines multi-omics data, with AI, digital twin and computational biology technologies, to decode the human immune system and identify new biomarkers and therapeutic targets in oncology and auto-immune diseases. AliveX Platform Solutions provides an end-to-end, integrated, AI immunology platform to support next generation R&D in drug discovery, significantly accelerate and increase R&D efficiency and improve the chance of clinical trial success. (64 words)